Anvil Partners LLP

We invest in a broad range of early stage businesses. The majority have been in the biomedical space, but we have also invested in internet technology and services (eg education). We look to invest and to provide corporate finance services as the companies develop up to exit, including IPOs and trade sales. Recent deals have included Desktop Genomics (gene research engine), RolePoint (recruitment), Myanmar Investments (investments in Myanmar), CyCell (personalised mobile phones) and Phynova Group (natural healthcare products).

Additional Information

Investor Type Angel Groups
Services Provided Live Pitch Presentations
Investment Stage Start-Up, Early Stage VC
Investment Opportunities Yes
Regions Covered National
Investment Range Less than £150k, £150k - £250k, £250k - £500k
Sectors Considered Food and Drink, Healthcare, Life Sciences
No. of opportunities selected each year 4
Company Initial Fee £0-£10,000 in shares
Company Success Fee 5% cash and 5% equity

Contact Form

Stay informed

  • This field is for validation purposes and should be left unchanged.